))
20: Entropix CEO Discusses Future Opportunities
Manage episode 342293132 series 3305030
A tartalmat a Deepbridge Capital Discovery Podcast and Deepbridge Capital biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Deepbridge Capital Discovery Podcast and Deepbridge Capital vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.
Rob Rule, CEO at Entropix, joins the Deepbridge Discovery Podcast to discuss the background behind setting up Entropix, the biggest challenges to date, the opportunities available for Entropix and his personal interests away from work.
Aboutr Entropix:
Entropix is a biotechnology company that specialises in the development of high-performance enzymes by employing state-of-the-art experimental molecular biology and computational methods.
Based at Sci-Tech Daresbury in Cheshire, UK, we use a highly specialised technology platform to identify novel genomic sequences and direct the evolution of novel enzymes with unique tertiary structures. Unique skills and capabilities in genetic engineering, computational gene sequence analysis, enzyme structure analysis, and machine learning enable us to improve the performance of enzymes for a range of biological and industrial applications.
- - -
Supporting growth-focused companies and entrepreneurs has never been more important, but it is important to understand the people and ideas behind such investment opportunities.
Join the Deepbridge Capital team each week as they discuss all things Deepbridge, speak with various investment experts within the company and discover more about the founders and CEOs’ running the portfolio companies Deepbridge invests in. Each episode contains an informal conversation to understand how these leaders and teams perform in order to achieve their goals. Investments in early-stage companies are illiquid and high risk – investors could lose all of their capital.
Aboutr Entropix:
Entropix is a biotechnology company that specialises in the development of high-performance enzymes by employing state-of-the-art experimental molecular biology and computational methods.
Based at Sci-Tech Daresbury in Cheshire, UK, we use a highly specialised technology platform to identify novel genomic sequences and direct the evolution of novel enzymes with unique tertiary structures. Unique skills and capabilities in genetic engineering, computational gene sequence analysis, enzyme structure analysis, and machine learning enable us to improve the performance of enzymes for a range of biological and industrial applications.
- - -
Supporting growth-focused companies and entrepreneurs has never been more important, but it is important to understand the people and ideas behind such investment opportunities.
Join the Deepbridge Capital team each week as they discuss all things Deepbridge, speak with various investment experts within the company and discover more about the founders and CEOs’ running the portfolio companies Deepbridge invests in. Each episode contains an informal conversation to understand how these leaders and teams perform in order to achieve their goals. Investments in early-stage companies are illiquid and high risk – investors could lose all of their capital.
48 epizódok
Megosztás
